Skip to content

Effect of Janosia Ashoka in polycystic ovarian syndrome

Effectiveness of Janosia Ashoka as compared to Homeopathic constitutional remedies in the management of polycystic ovarian syndrome - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081908
Enrollment
60
Registered
2025-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N80-N98- Noninflammatory disorders of female genital tract

Interventions

Intervention1: Janosia Ashoka: Participants who are in the interventional group recieve the drug Janosia Ashoka.the interventional drug will be given in 30C,200C 1M in centesimal scale depending on th

Sponsors

Dr Smitha M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: female pateints between the age group 18 to 30 yrs cases of polycystic syndrome diagnosed using Rotterdam Criteria

Exclusion criteria

Exclusion criteria: Clinically diagnosed cases of Diabetes mellitus, cushing syndrome.hyperprolactemiapatients on other medications

Design outcomes

Primary

MeasureTime frame
To access the mean difference in value in laboratory test in reduction in size and number of cysts as measured by USS before and after the administration of Janosia Ashoka and constitutional drugTimepoint: he primary outcome will be measured at the baseline treatment and after 6 months

Secondary

MeasureTime frame
To determine the difference in the quality of life in the score measured by polycystic syndrome questioaireTimepoint: the outcome will be measured at the baselinetreatment and after 6 momths

Countries

India

Contacts

Public ContactDr Susy Charles

Dr Padiar Memorial Homoeopathic Medical College

drsusycharles@gmail.com9447575888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026